Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
4/16/2019
WuXi Bio Set to Lose Contract Manufacturing of First Antibody-based HI...
4/16/2019
iCarbonX May Have to Divest from US Firm over National Security Concer...
4/16/2019
Chi-Med Files IPO in Hong Kong, Aiming to Raise $500M
4/16/2019
Bayer Pharma Hit with China-attributed Malware
4/16/2019
GenScript Starts Construction of GenScript-Legend Biotech Commercial M...
4/16/2019
China and Cuba Look to Enhance Cooperation in Biotech and Pharma
4/16/2019
'Reverse Patent Trolls' Plague Big Pharma in China
4/15/2019
Chinese Import of Medicine and Health Products Down in 2018 Due to Pri...
4/15/2019
Ten Workers Killed in Plant Incident at Qilu Tianhe Huishi Pharma
4/15/2019
Chairman of Sunflower Pharma Arrested for Murder
4/15/2019
Hope Medicine Licenses Bayer's Human Antibody Targeting the PRL Recept...
4/12/2019
China's Hansoh Pharma Re-files for Hong Kong IPO
4/12/2019
Novartis Submits New Drug Application for Gilenya (Fingolimod Hydrochl...
4/12/2019
CDE Seeks Comments on Draft ICH Guideline M10
4/12/2019
Recent Executive Moves
4/12/2019
Luqa Pharma and Ferrer Enter Agreement for Antibiotic Ozenoxacin in G...
4/11/2019
Ant Financial Aims to Disrupt China’s Health Insurance Space with Mut...
4/11/2019
NHSA Solicits Comments on Draft Rules for Use of Basic Medical Insuran...
4/11/2019
CDE Publicizes Six More Drug Applications To Be Granted Priority Revie...
4/11/2019
China Plans to Issue A New Set of Standards for Stem Cell Therapies
4/11/2019
Synaffix Announces $125M License Agreement with Shanghai Miracogen
4/11/2019
Catalent Opens 2nd Shanghai Facility to Optimize Clinical Supply Solut...
4/10/2019
HitGen and Kaken Enter into License Agreement for Novel Drug Developme...
4/10/2019
ReNeuron Licenses China Rights of Cell Therapy Programs to Fosun Pharm...
4/10/2019
NHC Issues Notice on Implementing Drug Consumption Surveillance and Ov...
4/10/2019
NDRC Solicits Comments on 2019 Edition of Guiding Catalogue for the Ad...
4/10/2019
BioAtla and BeiGene Form Global Collaboration for Novel Conditionally ...
4/10/2019
Chongqing Zhifei Bio Halts Production after Delay in License Renewal
4/10/2019
Sanofi CEO Pledges More Investment, R&D Facility and 16 New Drugs ...
4/10/2019
Sanofi Hopes to Catch Up with Digital Healthcare Service in China
Page:
231
/
720
Total number of articles:
21572
:
[First]
[<<]
[229]
[230]
[231]
[232]
[233]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit